Literature DB >> 25259933

Determination of the minimal important difference for the acute otitis media severity of symptom scale.

Nader Shaikh1, Howard E Rockette, Alejandro Hoberman, Marcia Kurs-Lasky, Jack L Paradise.   

Abstract

BACKGROUND: We previously developed and validated the acute otitis media severity of symptom (AOM-SOS) scale for rating symptoms of AOM in young children. In this report, we sought to estimate the minimal important difference (MID) for change in AOM-SOS scores.
METHODS: In a group of children 6-24 months of age with AOM enrolled in a recently reported placebo-controlled clinical trial of antibiotic efficacy, we compared changes in AOM-SOS scores with parental assessments of change over a 24-hour period. Mean absolute and mean relative change in scores in children reportedly exhibiting only a small degree of improvement were considered in arriving at an estimated MID. We then compared the proportions of children in the antibiotic and placebo groups, respectively, whose AOM-SOS scores changed more than the estimated MID at various time points after enrollment.
RESULTS: Data were available for 277 children. Children whose parents reported only a small degree of improvement 24 hours after enrollment had a mean decrease in AOM-SOS score of 3.8, or 55%, from baseline. We found the relative decrease more telling than the absolute decrease. The proportions of children in the antibiotic and placebo groups, respectively, whose AOM-SOS scores had decreased <55% on Day 7 were 12.3 and 23.8% (P=0.02), and during Days 4-7 were 28 and 40% (P=0.046).
CONCLUSIONS: We estimated the MID for change in AOM-SOS scores in young children and described use of the MID as an added metric in interpreting results from a clinical trial of antibiotic efficacy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25259933      PMCID: PMC4355180          DOI: 10.1097/INF.0000000000000557

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  8 in total

Review 1.  Minimal clinically important differences: review of methods.

Authors:  G Wells; D Beaton; B Shea; M Boers; L Simon; V Strand; P Brooks; P Tugwell
Journal:  J Rheumatol       Date:  2001-02       Impact factor: 4.666

2.  Adjusting for baseline: change or percentage change?

Authors:  L Kaiser
Journal:  Stat Med       Date:  1989-10       Impact factor: 2.373

3.  Measuring quality of life in children with asthma.

Authors:  E F Juniper; G H Guyatt; D H Feeny; P J Ferrie; L E Griffith; M Townsend
Journal:  Qual Life Res       Date:  1996-02       Impact factor: 4.147

Review 4.  Interpreting treatment effects in randomised trials.

Authors:  G H Guyatt; E F Juniper; S D Walter; L E Griffith; R S Goldstein
Journal:  BMJ       Date:  1998-02-28

5.  Treatment of acute otitis media in children under 2 years of age.

Authors:  Alejandro Hoberman; Jack L Paradise; Howard E Rockette; Nader Shaikh; Ellen R Wald; Diana H Kearney; D Kathleen Colborn; Marcia Kurs-Lasky; Sonika Bhatnagar; Mary Ann Haralam; Lisa M Zoffel; Carly Jenkins; Marcia A Pope; Tracy L Balentine; Karen A Barbadora
Journal:  N Engl J Med       Date:  2011-01-13       Impact factor: 91.245

6.  Responsiveness and construct validity of a symptom scale for acute otitis media.

Authors:  Nader Shaikh; Alejandro Hoberman; Jack L Paradise; Howard E Rockette; Marcia Kurs-Lasky; D Kathleen Colborn; Diana H Kearney; Lisa M Zoffel
Journal:  Pediatr Infect Dis J       Date:  2009-01       Impact factor: 2.129

7.  Development and preliminary evaluation of a parent-reported outcome instrument for clinical trials in acute otitis media.

Authors:  Nader Shaikh; Alejandro Hoberman; Jack L Paradise; Ellen R Wald; Galen E Switze; Marcia Kurs-Lasky; D Kathleen Colborn; Diana H Kearney; Lisa M Zoffel
Journal:  Pediatr Infect Dis J       Date:  2009-01       Impact factor: 2.129

8.  Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance.

Authors: 
Journal:  Health Qual Life Outcomes       Date:  2006-10-11       Impact factor: 3.186

  8 in total
  4 in total

1.  Shortened Antimicrobial Treatment for Acute Otitis Media in Young Children.

Authors:  Alejandro Hoberman; Jack L Paradise; Howard E Rockette; Diana H Kearney; Sonika Bhatnagar; Timothy R Shope; Judith M Martin; Marcia Kurs-Lasky; Susan J Copelli; D Kathleen Colborn; Stan L Block; John J Labella; Thomas G Lynch; Norman L Cohen; MaryAnn Haralam; Marcia A Pope; Jennifer P Nagg; Michael D Green; Nader Shaikh
Journal:  N Engl J Med       Date:  2016-12-22       Impact factor: 91.245

2.  Development and Modification of an Outcome Measure to Follow Symptoms of Children with Sinusitis.

Authors:  Nader Shaikh; Ellen R Wald; Jong-Hyeon Jeong; Marcia Kurs-Lasky; David Nash; Michael E Pichichero; Diana H Kearney; Mary Ann Haralam; A'Delbert Bowen; Lynda L Flom; Alejandro Hoberman
Journal:  J Pediatr       Date:  2018-12-10       Impact factor: 4.406

3.  Reduced-Concentration Clavulanate for Young Children with Acute Otitis Media.

Authors:  Alejandro Hoberman; Jack L Paradise; Howard E Rockette; Jong-Hyeon Jeong; Diana H Kearney; Sonika Bhatnagar; Timothy R Shope; Gysella Muñiz; Judith M Martin; Marcia Kurs-Lasky; MaryAnn Haralam; Marcia A Pope; Jennifer P Nagg; Wenchen Zhao; Mohammad Kowser Miah; Jan Beumer; Raman Venkataramanan; Nader Shaikh
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

4.  Tympanostomy Tubes or Medical Management for Recurrent Acute Otitis Media.

Authors:  Alejandro Hoberman; Diego Preciado; Jack L Paradise; David H Chi; MaryAnn Haralam; Stan L Block; Diana H Kearney; Sonika Bhatnagar; Gysella B Muñiz Pujalt; Timothy R Shope; Judith M Martin; Daniel E Felten; Marcia Kurs-Lasky; Hui Liu; Kristin Yahner; Jong-Hyeon Jeong; Norman L Cohen; Brian Czervionke; Jennifer P Nagg; Joseph E Dohar; Nader Shaikh
Journal:  N Engl J Med       Date:  2021-05-13       Impact factor: 91.245

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.